Janine Reichenbach

Has grant

Head Division of Somatic Gene Therapy

University Children's Hospital Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Janine Reichenbach is the Head of the Division of Somatic Gene Therapy at the University Children's Hospital Zurich, Switzerland. Her research focuses on somatic gene therapy, healthcare resource allocation for rare diseases, and genetic diagnostics. Recent publications include studies on gene editing, clinical efficacy of monoclonal antibodies, and management recommendations for severe immune deficiencies.

Recent Grants

Grant: Close

Hematopoietic Stem Cell Gene Therapy for treatment of Ataxia telangiectasia (A-T)

Open Date: 2020-05-01

Close Date: 2024-04-30

Grant: Close

The influence of immunological PD-1 checkpoints on inflammation regulation by ROS and autophagy

Open Date: 2019-07-01

Close Date: 2025-06-30

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (19)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

SWITZERLAND

Janine Reichenbach

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Healthcare resource allocation for rare diseases: an exploratory survey of Swiss citizens’ preferences

Sichere Gentherapie für Septische Granulomatose

Centralized rapid genetic diagnosis of combined immunodeficiency in Japan

Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Targeted knock-in of <i>NCF1</i> cDNA into the <i>NCF2</i> locus leads to myeloid phenotypic correction of p47 <sup><i>phox</i></sup> -deficient chronic granulomatous disease.

Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements

Expression of a large coding sequence: Gene therapy vectors for Ataxia Telangiectasia.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendations

Membrane Dynamics and Organization of the Phagocyte NADPH Oxidase in PLB-985 Cells

Collaborators (19)

Fabio Candotti

Lucas Kissling

Ann Gardulf

Robbert Bredius

Nikolaus Rieber

Matthias R. Baumgartner

Sophie Dupré

Raphael Johannes Scheible

Geraldine Blanchard-Rohner

Gerald Schwank

Daan Swarts

Nikola Biller-Andorno

Ute Modlich

Mathias M Hauri-Hohl

Antonios Kolios

Ulrich Siler

Jiří Litzman

Federico Germani

Markus G Seidel

Make your next move.